Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Early hepatocyte DNA synthetic response posthepatectomy is modulated by IL-6 trans-signaling and PI3K/AKT activation.

Nechemia-Arbely Y, Shriki A, Denz U, Drucker C, Scheller J, Raub J, Pappo O, Rose-John S, Galun E, Axelrod JH.

J Hepatol. 2011 May;54(5):922-9. doi: 10.1016/j.jhep.2010.08.017. Epub 2010 Oct 31.

PMID:
21145830
2.

Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma.

Pantic M, Schroettner P, Pfeifer D, Rawluk J, Denz U, Schmitt-Gräff A, Veelken H, Wäsch R, Engelhardt M.

Leukemia. 2010 Apr;24(4):885-90. doi: 10.1038/leu.2009.294. Epub 2010 Jan 21. No abstract available.

PMID:
20090779
3.

Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation.

Denz U, Bertz H, Ihorst G, Wäsch R, Finke J.

Bone Marrow Transplant. 2010 Aug;45(8):1309-15. doi: 10.1038/bmt.2009.341. Epub 2010 Jan 11.

PMID:
20062094
4.

Thalidomide in consecutive multiple myeloma patients: single-center analysis on practical aspects, efficacy, side effects and prognostic factors with lower thalidomide doses.

Haas PS, Denz U, Ihorst G, Engelhardt M.

Eur J Haematol. 2008 Apr;80(4):303-9. doi: 10.1111/j.1600-0609.2007.01022.x. Epub 2007 Dec 21.

PMID:
18182082
5.

State of the art therapy in multiple myeloma and future perspectives.

Denz U, Haas PS, Wäsch R, Einsele H, Engelhardt M.

Eur J Cancer. 2006 Jul;42(11):1591-600. Epub 2006 Jul 3. Review.

PMID:
16815703

Supplemental Content

Support Center